VNDA Next Earnings Date Notes

— Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development & commercialization of innovative therapies to address high unmet medical needs in neuroscience & orphan diseases. Vanda's pipeline includes FDA-approved Hetlioz (tasimelteon) for non-24-hour sleep-wake disorder & Smith-Magenis Syndrome, as well as Fanapt (iloperidone) for schizophrenia, in addition to several late- and early-stage investigational products. When listening to the upcoming earnings call, investors should focus on key metrics like Net Product Revenues, particularly driven by Hetlioz & Fanapt sales, as these form the core of Vanda’s current revenues. Also important are R&D expense trends, since pipeline progression is vital to the long-term story, and cash & equivalents in light of ongoing development costs versus revenue run rates. Watch for management commentary on regulatory updates, potential product label expansions, and commercial partnerships, as these can significantly impact VNDA’s growth trajectory. The company’s ability to generate sustainable cash flow while advancing its pipeline will be central to understanding Vanda’s potential for long-term value creation. The next projected earnings date for VNDA is 5/6/2026 after close (stay tuned for a confirmed earnings date once announced).

VNDA Next Earnings Date FAQ

On this page we presented the VNDA Next Earnings Date information for Vanda Pharma along with recent past earnings dates. For Q4 of 2025, VNDA reported earnings of -2.390/share, with the earnings report taking place on 2/11/2026. For Q3 of 2025, VNDA reported earnings of -0.380/share, with the earnings report taking place on 10/29/2025. For Q2 of 2025, VNDA reported earnings of -0.460/share, with the earnings report taking place on 7/31/2025. For Q1 of 2025, VNDA reported earnings of -0.500/share, with the earnings report taking place on 5/7/2025. For Q4 of 2024, VNDA reported earnings of -0.080/share, with the earnings report taking place on 2/13/2025. Based on these past earnings dates, the projected next earnings date for VNDA is 5/6/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Vanda Pharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Vanda Pharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Vanda Pharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next VNDA earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up VNDA's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the VNDA next earnings date.